Cargando…
Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model
OBJECTIVE: The pathogenesis of diabetic nephropathy is complex and involves activation of multiple pathways leading to kidney damage. An important role for altered lipid metabolism via sterol regulatory element binding proteins (SREBPs) has been recently recognized in diabetic kidney disease. Our pr...
Autores principales: | Wang, Xiaoxin X., Jiang, Tao, Shen, Yan, Caldas, Yupanqui, Miyazaki-Anzai, Shinobu, Santamaria, Hannah, Urbanek, Cydney, Solis, Nathaniel, Scherzer, Pnina, Lewis, Linda, Gonzalez, Frank J., Adorini, Luciano, Pruzanski, Mark, Kopp, Jeffrey B., Verlander, Jill W., Levi, Moshe |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963551/ https://www.ncbi.nlm.nih.gov/pubmed/20699418 http://dx.doi.org/10.2337/db10-0019 |
Ejemplares similares
-
The Farnesoid X Receptor: Good for BAD
por: Keely, Stephen J., et al.
Publicado: (2016) -
Farnesoid X receptor (FXR): Structures and ligands
por: Jiang, Longying, et al.
Publicado: (2021) -
Role of Farnesoid X Receptor and Bile Acids in Hepatic Tumor Development
por: Takahashi, Shogo, et al.
Publicado: (2018) -
Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
por: She, Jianglian, et al.
Publicado: (2022) -
Liver X Receptor Modulates Diabetic Retinopathy Outcome in a Mouse Model of Streptozotocin-Induced Diabetes
por: Hazra, Sugata, et al.
Publicado: (2012)